| Cat. No. |
Product Name |
Information |
| PC-72537 |
AL-GDa62
SUMOylation inhibitor
|
AL-GDa62 is a specific inhibitor of TCOF1, ARPC5, and UBC9, inhibits SUMOylation at low micromolar concentrations. |
| PC-72531 |
HLM006474
E2F inhibitor
|
HLM006474 is a selective small-molecule E2F inhibitor, inhibits E2F4 DNA-binding with IC50 of 29.8 uM in A549 cells. |
| PC-72525 |
X5050
REST inhibitor
|
X5050 (X-5050) is a small molecule that inhibits REST silencing in a RE1-dependent manner, targeted REST degradation. |
| PC-72504 |
ARSA-IN-1r
ARSA inhibitor
|
ARSA-IN-1r (ARSAi) is the first reversible inhibitor of human Arylsulfatase A (ARSA) with SPR KD of 21 uM and IC50 of 13.2 uM. |
| PC-72487 |
RIOK2 inhibitor 10
RIOK2 inhibitor
|
RIOK2 inhibitor 10 is a specific human RIOK2 inhibitor with Kd of 160 nM. |
| PC-72486 |
RIOK2 inhibitor 9
RIOK2 inhibitor
|
RIOK2 inhibitor 9 is a specific human RIOK2 inhibitor with Kd of 520 nM. |
| PC-72477 |
CPSF3 inhibitor 2
CPSF3 inhibitor
|
CPSF3 inhibitor 2 is a small moleculemodulator of pre-mRNA processing, targets and binds to human CPSF3 (Kd=370 nM). |
| PC-72465 |
I-OMe-AG-538
PI5P4Kα inhibitor
|
I-OMe-AG-538 (I-OMe-Tyrphostin AG 538) is an ATP-competitive inhibitor of PI5P4Kα with an IC50 of 1 uM, also inhibits the PIP4K2A activity with IC50 of 2.1 uM. |
| PC-72459 |
JumOCA peptide Tat
OCA-B peptide inhibitor
|
JumOCA peptide Tat is a a peptide corresponding to the OCA-B N terminus, as C-terminal fusions to the HIV trans-activator of transcription (Tat) protein for membrane permeability. |
| PC-72458 |
JumOCA peptide
OCA-B peptide inhibitor
|
JumOCA peptide (VKELLRRKRGH) is a peptide corresponding to the OCA-B N terminus, membrane-penetrating OCA-B peptide inhibitor. |
| PC-72447 |
SBI-581
TAO3 inhibitor
|
SBI-581 (SBI 581) is a potent, selective inhibitor of serine-threonine kinase TAO3 with IC50 of 42 nM, an STE20-like kinase of the GCK subfamily. |
| PC-72440 |
AQX-435
SHIP1 activator
|
AQX-435 (AQX435) is a novel small molecule SHIP1 activator, inhibits anti-IgM-induced PI3K-mediated signaling, including induction of AKT phosphorylation and MYC expression, without effects on upstream SYK phosphorylation. |
